Inflammatory Modulation in Pregnancy Using Enriched Marine Oil Supplements and Their Possible Role in the Prevention of Obstetric Complications
Preprint
- 11 April 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The use of selective pro resolving mediators including the monohydroxylates are promising substances for the management of different acute and chronic diseases.In the field of obstetrics many clinical entities like uterine contractions or the occurrence of pre-eclampsia are still serious complications during pregnancy.The use of enriched marine oil nutritional’s may contribute to an attenuation of these diseases as the containing selective pro resolving mediators exhibit pro resolutive actions that can positively modulate inflammatory diseases and those leading to serious obstetrical complications.Keywords
All Related Versions
This publication has 85 references indexed in Scilit:
- Omega-3 fatty acid addition during pregnancyCochrane Database of Systematic Reviews, 2018
- Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significanceAmerican Journal of Obstetrics and Gynecology, 2015
- Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferationThe Journal of Pathology, 2012
- Novel Proresolving Aspirin-Triggered DHA PathwayChemistry & Biology, 2011
- Inflammatory pattern recognition receptors and their ligands: factors contributing to the pathogenesis of preeclampsiaInflammation Research, 2011
- Diagnosis and Management of Clinical ChorioamnionitisClinics in Perinatology, 2010
- Nonresolving InflammationCell, 2010
- Lipoxins and new lipid mediators in the resolution of inflammationCurrent Opinion in Pharmacology, 2006
- A review of premature birth and subclinical infectionAmerican Journal of Obstetrics and Gynecology, 1992
- Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986American Journal of Obstetrics and Gynecology, 1990